{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T13:30:52Z","timestamp":1788269452861,"version":"build-2803163510"},"reference-count":54,"publisher":"Wiley","issue":"10","license":[{"start":{"date-parts":[[2007,5,21]],"date-time":"2007-05-21T00:00:00Z","timestamp":1179705600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurogastroenterology Motil"],"published-print":{"date-parts":[[2007,10]]},"abstract":"<jats:p><jats:bold>Abstract\u2002<\/jats:bold> Opioid neurons exhibit tonic restraint on intestinal motility; opioid antagonists stimulate peristalsis and increase transit. <jats:italic>In vitro<\/jats:italic>, 5\u2010hydroxytryptamine (5\u2010HT<jats:sub>4<\/jats:sub>) agonists combined with selective opioid antagonists significantly increased colonic propulsion relative to a 5\u2010HT<jats:sub>4<\/jats:sub> agonist alone. We hypothesized that the combination of 5\u2010HT<jats:sub>4<\/jats:sub> agonist and non\u2010selective opioid antagonist enhances intestinal transit more than either treatment alone in female constipation\u2010predominant irritable bowel syndrome (C\u2010IBS) patients. Our aim was to examine the effect of tegaserod 6\u2003mg b.i.d. alone and combined with naltrexone 50\u2003mg on intestinal transit and stool characteristics in females with C\u2010IBS. Forty\u2010eight patients were randomized to tegaserod alone, naltrexone alone or in combination with tegaserod or placebo for 6\u2003days. Small bowel, ascending colon half\u2010life (in pharmacokinetics) (<jats:italic>t<\/jats:italic><jats:sub>1\/2<\/jats:sub>), and colonic geometric centre (8, 24, 48\u2003h) were assessed by scintigraphy. Tegaserod increased small bowel (<jats:italic>P<\/jats:italic>\u2003&lt;\u20030.01) and colon transit (<jats:italic>P<\/jats:italic>\u2003&lt;\u20030.01). Naltrexone did not accelerate colonic transit relative to placebo. Combination treatment did not significantly accelerate transit relative to tegaserod alone. Tegaserod and tegaserod with naltrexone resulted in looser stool form (<jats:italic>P<\/jats:italic>\u2003&lt;\u20030.01). In female C\u2010IBS patients, tegaserod accelerates small bowel and colon transit and contributed to looser stool consistency. Use of naltrexone, 50\u2003mg, does not support the hypothesis that combination of 5\u2010HT<jats:sub>4<\/jats:sub> agonist and non\u2010selective opioid antagonist enhances intestinal transit.<\/jats:p>","DOI":"10.1111\/j.1365-2982.2007.00944.x","type":"journal-article","created":{"date-parts":[[2007,5,22]],"date-time":"2007-05-22T21:18:57Z","timestamp":1179868737000},"page":"821-830","source":"Crossref","is-referenced-by-count":15,"title":["Does co\u2010administration of a non\u2010selective opiate antagonist enhance acceleration of transit by a 5\u2010HT<sub>4<\/sub> agonist in constipation\u2010predominant irritable bowel syndrome? A randomized controlled trial"],"prefix":"10.1111","volume":"19","author":[{"given":"A. E.","family":"Foxx\u2010orenstein","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Camilleri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L. A.","family":"Szarka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Mckinzie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Burton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Thomforde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Baxter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. R.","family":"Zinsmeister","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2007,9,19]]},"reference":[{"key":"e_1_2_7_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(93)90705-L"},{"key":"e_1_2_7_3_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.mcg.0000156403.37240.30"},{"key":"e_1_2_7_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1542-3565(04)00726-8"},{"key":"e_1_2_7_5_2","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2005.09.031"},{"key":"e_1_2_7_6_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra035579"},{"key":"e_1_2_7_7_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2982.2004.00632.x"},{"key":"e_1_2_7_8_2","first-page":"A754","article-title":"Stimulation of colonic propulsion by 5\u2010HT4 receptor agonists: synergism by delta opioid receptor agonists","volume":"112","author":"Jin JG","year":"1997","journal-title":"Gastroenterology"},{"issue":"2","key":"e_1_2_7_9_2","first-page":"G226","article-title":"Role of opioid neurons in the regulation of intestinal peristalsis","volume":"253","author":"Grider JR","year":"1987","journal-title":"Am J Physiol"},{"issue":"4","key":"e_1_2_7_10_2","first-page":"G696","article-title":"Interplay of somatostatin, opioid, and GABA neurons in the regulation of the peristaltic reflex","volume":"267","author":"Grider JR","year":"1994","journal-title":"Am J Physiol"},{"key":"e_1_2_7_11_2","doi-asserted-by":"publisher","DOI":"10.1679\/aohc.53.467"},{"issue":"1","key":"e_1_2_7_12_2","first-page":"G103","article-title":"Identification of opioid receptors on gastric muscle cells by selective receptor protection","volume":"260","author":"Grider JR","year":"1991","journal-title":"Am J Physiol"},{"key":"e_1_2_7_13_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00265977"},{"key":"e_1_2_7_14_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.82.6.1860"},{"key":"e_1_2_7_15_2","first-page":"965","article-title":"Inhibition of cholinergic transmission by opiates in ileal myenteric plexus is mediated by kappa receptor. Involvement of regulatory inhibitory G protein and calcium N\u2010channels","volume":"268","author":"Kojima Y","year":"1994","journal-title":"J Pharmacol Exp Ther"},{"key":"e_1_2_7_16_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00176339"},{"key":"e_1_2_7_17_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.1992.tb14448.x"},{"key":"e_1_2_7_18_2","doi-asserted-by":"publisher","DOI":"10.1096\/fasebj.9.7.7737460"},{"key":"e_1_2_7_19_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjp.0703954"},{"key":"e_1_2_7_20_2","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.103.053256"},{"issue":"5","key":"e_1_2_7_21_2","first-page":"G979","article-title":"5\u2010HT4 receptor agonists and delta\u2010opioid receptor antagonists act synergistically to stimulate colonic propulsion","volume":"275","author":"Foxx\u2010Orenstein AE","year":"1998","journal-title":"Am J Physiol"},{"key":"e_1_2_7_22_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2005.40749.x"},{"key":"e_1_2_7_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(00)70251-4"},{"key":"e_1_2_7_24_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.2001.01094.x"},{"key":"e_1_2_7_25_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.2002.01372.x"},{"key":"e_1_2_7_26_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.52.5.671"},{"key":"e_1_2_7_27_2","doi-asserted-by":"publisher","DOI":"10.1080\/00365520310006748"},{"key":"e_1_2_7_28_2","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-200363070-00003"},{"key":"e_1_2_7_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/0016-5085(93)90896-K"},{"key":"e_1_2_7_30_2","first-page":"1471","article-title":"Audit of constipation in a tertiary referral gastroenterology practice","volume":"90","author":"Surrenti E","year":"1995","journal-title":"Am J Gastroenterol"},{"key":"e_1_2_7_31_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.2002.01344.x"},{"key":"e_1_2_7_32_2","first-page":"1807","article-title":"Colonic transit scintigraphy labeled activated charcoal compared with ion exchange pellets","volume":"38","author":"Burton DD","year":"1997","journal-title":"J Nucl Med"},{"key":"e_1_2_7_33_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0025-6196(12)62169-7"},{"key":"e_1_2_7_34_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra020995"},{"key":"e_1_2_7_35_2","volume-title":"Tegaserod Maleate","author":"Zelnorm","year":"2004"},{"key":"e_1_2_7_36_2","volume-title":"Tegaserod Maleate","author":"Zelnorm","year":"2002"},{"key":"e_1_2_7_37_2","unstructured":"ReVia package insert. Rev 3\/97 Rec 6\/97. DuPont USA."},{"key":"e_1_2_7_38_2","unstructured":"ReVia package insert. Rev 2\/96 Rec 2\/97. DuPont Canada."},{"key":"e_1_2_7_39_2","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-198835030-00002"},{"key":"e_1_2_7_40_2","first-page":"273","article-title":"Review of naltrexone, a long\u2010acting opiate antagonist","volume":"3","author":"Crabtree B","year":"1984","journal-title":"Clin Pharm"},{"key":"e_1_2_7_41_2","first-page":"369","article-title":"Metabolism and disposition of naltrexone in man after oral and intravenous administration","volume":"9","author":"Peres\u2010Reyes M","year":"1981","journal-title":"Drug Metab Dispos"},{"key":"e_1_2_7_42_2","first-page":"295","volume-title":"Endocrinology of the Gastrointestinal System","author":"Grider JR","year":"1998"},{"issue":"1","key":"e_1_2_7_43_2","first-page":"G40","article-title":"Colonic peristaltic reflex: identification of vasoactive intestinal peptide as mediator of descending relaxation","volume":"251","author":"Grider JR","year":"1986","journal-title":"Am J Physiol"},{"key":"e_1_2_7_44_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.51.6.781"},{"key":"e_1_2_7_45_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01297027"},{"key":"e_1_2_7_46_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.33.6.818"},{"key":"e_1_2_7_47_2","doi-asserted-by":"publisher","DOI":"10.1053\/gast.2000.8553"},{"issue":"6","key":"e_1_2_7_48_2","first-page":"G1139","article-title":"CGRP as a transmitter in the sensory pathway mediating peristaltic reflex","volume":"266","author":"Grider JR","year":"1994","journal-title":"Am J Physiol"},{"key":"e_1_2_7_49_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1542-3565(05)00434-9"},{"key":"e_1_2_7_50_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1542-3565(04)00391-X"},{"key":"e_1_2_7_51_2","doi-asserted-by":"publisher","DOI":"10.1016\/0016-5085(91)90466-X"},{"key":"e_1_2_7_52_2","doi-asserted-by":"publisher","DOI":"10.1016\/0016-5085(92)91789-7"},{"key":"e_1_2_7_53_2","doi-asserted-by":"publisher","DOI":"10.1016\/0016-5085(78)90246-9"},{"key":"e_1_2_7_54_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2006.03049.x"},{"key":"e_1_2_7_55_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2005.078634"}],"container-title":["Neurogastroenterology &amp; Motility"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2982.2007.00944.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2982.2007.00944.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,10]],"date-time":"2023-10-10T22:51:55Z","timestamp":1696978315000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2982.2007.00944.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,9,19]]},"references-count":54,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2007,10]]}},"alternative-id":["10.1111\/j.1365-2982.2007.00944.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2982.2007.00944.x","archive":["Portico"],"relation":{},"ISSN":["1350-1925","1365-2982"],"issn-type":[{"value":"1350-1925","type":"print"},{"value":"1365-2982","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,9,19]]}}}